drugset / Trial / NCT02344511
Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis
RandomizedParallel-groupTriple-blindTreatment
Summary
Dalbavancin for Pediatric Osteomyelitis
Timeline
- Start
- 2016-03
- Primary completion
- 2018-10
- Completion
- 2019-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cefazolin | Small molecule | 25 mg/kg | — |
| Subject | Dalbavancin | Other / unclassified | 10 mg/kg | Intravenous |
| Subject | Dalbavancin | Other / unclassified | 15 mg/kg | Intravenous |
| Comparator | Vancomycin | Other / unclassified | 15 mg/kg | — |
| Comparator | nafcillin | Small molecule | 50 mg/kg | — |
| Comparator | oxacillin | Small molecule | 50 mg/kg | — |